2011•Alzheimer s & DementiaOpen access

P3‐120: Mis‐splicing of Tau Exon 2 and Exon 10 in myotonic dystrophy brain would result from different mechanisms

Marie‐Laure Caillet‐Boudin, Claire‐Marie Dhaenens, Marie‐Lise Frandemiche, Hélène Tran, Céline Carpentier, Francisco-José Fernández-Gómez, Andone Sistiaga, María Goicoechea, Edwige Van Brussel, Hélène Obriot, Sabiha Eddarkaoui, Marie‐Helene Gavaert, Bernard Sablonnière, Adolfo Lopez‐de‐munain, Luc Buée, Susanna Schraen‐Maschke, Nicolas Sergeant

Open full text 0 citations

Abstract

The mis-splicing of Tau is instrumental to the development of neurofibrillary degeneration (NFD) naturopathies such as FTDP-17 in which MAPTmutations lead to a defective splicing of Tau. A mis-splicing of Tau is also observed in the brain and muscle of patients affected by myotonic dystrophy of type I (DM1). Moreover, this Tau mis-splicing is associated with the development of NFD. DM1 is a neuromuscular disease characterized by an unstable CTG expansion. This mutation is responsible for a toxic gain of RNA-function, leading to the gain or loss of function of several splicing factors, including the CELF and MBNL families, respectively. It ultimately leads to an indirect mis-splicing of numerous transcripts. In regards to Tau mis-splicing, exon-2 inclusion is highly decreased in DM1 brains. In contrast, a mis-splicing of Tau exon-10 is seldom observed in DM1 but the mechanisms triggering this mis-splicing event remain unknown. We herein aimed to gain further insights into these molecular mechanisms involved in normal and pathological splicing of Tau exons 2 and 10 using cell-based models. Two among the brains of 5 DM1 patients showed an exon-10 mis-splicing whereas exon-2 inclusion was reduced in all DM1 patients. The over-expression of long stretches of CTGrepeats promoted the exclusion of both Tau exon 2 and exon 10. Interestingly, MBNL1 loss of expression efficiently repressed Tau exon 2 inclusion but failed to modulate Tau exon-10 splicing. Analyzing the splicing functions of three major CELF splicing factors, we showed that CELF 4 acts as a repressor for exon-2 or as an enhancer for exon-10 inclusion. In sharp contrast, CELF2 repressed both exons 2 and 10 inclusions whereas CELF1 was inefficient to modulate Tau splicing. In addition, 2D electrophoresis coupled to western-blotting suggest a possible change inbrain CELF2 activity induced by its hyperphosphorylation in DM1. Altogether, we showed that MBNL1 and CELF2 are implicated in the mis-splicing of Tau-exons 2 and 10, respectively, but not CELF1. Moreover, our Tau splicing study also suggests that two different mechanisms may contribute to the mis-splicing of several targets in DM1.

Open-access reader

About this research paper

What this paper is about

The mis-splicing of Tau is instrumental to the development of neurofibrillary degeneration (NFD) naturopathies such as FTDP-17 in which MAPTmutations lead to a defective splicing of Tau. A mis-splicing of Tau is also observed in the brain and muscle of patients affected by myotonic dystrophy of type I (DM1). Moreover, this Tau mis-splicing is associated with the development of NFD. DM1 is a neuromuscular disease characterized by an unstable CTG expansion. This mutation is responsible for a toxic gain of RNA-function, leading to the gain or loss of function of several splicing factors, including the CELF and MBNL families, respectively. It ultimately leads to an indirect mis-splicing of numerous transcripts. In regards to Tau mis-splicing, exon-2 inclusion is highly decreased in DM1 brains. In contrast, a mis-splicing of Tau exon-10 is seldom observed in DM1 but the mechanisms triggering this mis-splicing event remain unknown. We herein aimed to gain further insights into these molecular mechanisms involved in normal and pathological splicing of Tau exons 2 and 10 using cell-based models. Two among the brains of 5 DM1 patients showed an exon-10 mis-splicing whereas exon-2 inclusion was reduced in all DM1 patients. The over-expression of long stretches of CTGrepeats promoted the exclusion of both Tau exon 2 and exon 10. Interestingly, MBNL1 loss of expression efficiently repressed Tau exon 2 inclusion but failed to modulate Tau exon-10 splicing. Analyzing the splicing functions of three major CELF splicing factors, we showed that CELF 4 acts as a repressor for exon-2 or as an enhancer for exon-10 inclusion. In sharp contrast, CELF2 repressed both exons 2 and 10 inclusions whereas CELF1 was inefficient to modulate Tau splicing. In addition, 2D electrophoresis coupled to western-blotting suggest a possible change inbrain CELF2 activity induced by its hyperphosphorylation in DM1. Altogether, we showed that MBNL1 and CELF2 are implicated in the mis-splicing of Tau-exons 2 and 10, respectively, but not CELF1. Moreover, our Tau splicing study also suggests that two different mechanisms may contribute to the mis-splicing of several targets in DM1.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The mis-splicing of Tau is instrumental to the development of neurofibrillary degeneration (NFD) naturopathies such as FTDP-17 in which MAPTmutations lead to a defective splicing of Tau. A mis-splicing of Tau is also observed in the brain and muscle of patients affected by myotonic dystrophy of type I (DM1). Moreover, this Tau mis-splicing is associated with the development of NFD. DM1 is a neuromuscular disease characterized by an unstable CTG expansion. This mutation is responsible for a toxic gain of RNA-function, leading to the gain or loss of function of several splicing factors, including the CELF and MBNL families, respectively. It ultimately leads to an indirect mis-splicing of numerous transcripts. In regards to Tau mis-splicing, exon-2 inclusion is highly decreased in DM1 brains. In contrast, a mis-splicing of Tau exon-10 is seldom observed in DM1 but the mechanisms triggering this mis-splicing event remain unknown. We herein aimed to gain further insights into these molecular mechanisms involved in normal and pathological splicing of Tau exons 2 and 10 using cell-based models. Two among the brains of 5 DM1 patients showed an exon-10 mis-splicing whereas exon-2 inclusion was reduced in all DM1 patients. The over-expression of long stretches of CTGrepeats promoted the exclusion of both Tau exon 2 and exon 10. Interestingly, MBNL1 loss of expression efficiently repressed Tau exon 2 inclusion but failed to modulate Tau exon-10 splicing. Analyzing the splicing functions of three major CELF splicing factors, we showed that CELF 4 acts as a repressor for exon-2 or as an enhancer for exon-10 inclusion. In sharp contrast, CELF2 repressed both exons 2 and 10 inclusions whereas CELF1 was inefficient to modulate Tau splicing. In addition, 2D electrophoresis coupled to western-blotting suggest a possible change inbrain CELF2 activity induced by its hyperphosphorylation in DM1. Altogether, we showed that MBNL1 and CELF2 are implicated in the mis-splicing of Tau-exons 2 and 10, respectively, but not CELF1. Moreover, our Tau splicing study also suggests that two different mechanisms may contribute to the mis-splicing of several targets in DM1.

Key concepts: Exon, RNA splicing, Myotonic dystrophy, Alternative splicing, Minigene, Exonic splicing enhancer, Splicing factor, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
P3‐120: Mis‐splicing of Tau Exon 2 and Exon 10 in myotonic dystrophy brain would result from different mechanisms — Research Paper | ScholarLens